Bardy Diagnostics, developers of a remote cardiac monitoring chest patch, has raised $35.5 million to help fund its platform and expand its sales force. The series B round, led by River Cities Capital ...

SEATTLE, Oct. 24, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected ...

Remote patient monitoring has attracted a surge of investment activity during the pandemic, with medtech players jumping into the market through acquisitions. In addition to Hillrom's BardyDx purchase ...

Bardy Diagnostics, maker of an adhesive ambulatory cardiac patch for remote monitoring, has raised $35.5 million in a Series B funding round led by River Cities Capital Funds. The round also featured ...

In another deal for cardiac monitoring, Hillrom (NYSE: HRC) will buy Seattle-based startup Bardy Diagnostics for $375 million. The company, which was founded in 2013 by electrophysiologist Dr. Gust ...

SEATTLE, May 9, 2018 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation ...

Seattle-based medical device company Bardy Diagnostics today announced a $35.5 million funding round led by River Cities Capital Fund. The company makes the Carnation Ambulatory Monitor (CAM), which ...

CHICAGO, Jan. 19, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a ...

Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The ...